map Central

AMENDED NOTIFICATION OF THE NEW DRUGS AND CLINICAL TRIALS (AMENDMENT) RULES, 2022(DATED - 13.01.2022)

Updated on:13th Jan, 2022
This notification has come into effect from 13.01.2022. In the New Drugs and Clinical Trials Rules, 2019, in rule 2, in sub-rule (1), in clause (w), in sub-clause (v), for the words “stem cell derived product”, the words “cell or stem cell derived product” shall be substituted, refer attachment for further details
Download download